1-11 of 11
Authors: Mario M Dorostkar
Journal Article
Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes Open Access
Neuro-Oncology, Volume 26, Issue 5, May 2024, Pages 935–949, https://doi.org/10.1093/neuonc/noad265
Published: 30 December 2023
Journal Article
MDB-19. MULTIOMIC PROFILING OF MEDULLOBLASTOMA REVEALS SUBTYPE-SPECIFIC TARGETABLE ALTERATIONS AT THE PROTEOME AND N-GLYCAN LEVEL Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i66, https://doi.org/10.1093/neuonc/noad073.252
Published: 12 June 2023
Journal Article
Adult intracranial ependymoma—relevance of DNA methylation profiling for diagnosis, prognosis, and treatment Free
Neuro-Oncology, Volume 25, Issue 7, July 2023, Pages 1286–1298, https://doi.org/10.1093/neuonc/noad030
Published: 03 February 2023
Journal Article
EPEN-27. Epigenetic dissection of spinal ependymomas (SP-EPN) separates tumors with and withoutNF2 mutation Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i44–i45, https://doi.org/10.1093/neuonc/noac079.163
Published: 03 June 2022
Journal Article
HGG-45. Characterization of spinal diffuse midline gliomas, H3 K28M-mutant Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i71, https://doi.org/10.1093/neuonc/noac079.260
Published: 03 June 2022
Journal Article
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease Free
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1689–1699, https://doi.org/10.1093/neuonc/noac088
Published: 05 April 2022
Journal Article
PATH-32. EXTENT, PATTERN, AND PROGNOSTIC VALUE OF MGMT PROMOTOR METHYLATION: DOES IT DIFFER BETWEEN GLIOBLASTOMA AND IDH-WILDTYPE/TERT-MUTATED ASTROCYTOMA? Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi122, https://doi.org/10.1093/neuonc/noab196.484
Published: 12 November 2021
Journal Article
PATH-34. MOLECULAR AND CLINICAL HETEROGENEITY WITHIN SPINAL EPENDYMOMAS Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi122, https://doi.org/10.1093/neuonc/noab196.486
Published: 12 November 2021
Journal Article
BIOM-15. SUBVENTRICULAR ZONE INVOLVEMENT IS ASSOCIATED WITH WORSE OUTCOME IN GLIOMA WHO GRADE II INDEPENDENT OF MOLECULAR MARKERS Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii4–ii5, https://doi.org/10.1093/neuonc/noaa215.015
Published: 09 November 2020
Journal Article
PATH-28. EXTENT AND PROGNOSTIC VALUE OF MGMT PROMOTOR METHYLATION DEPEND ON IDH MUTATION AND 1p19q CO-DELETION IN GLIOMA WHO GRADE II Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii170, https://doi.org/10.1093/neuonc/noaa215.709
Published: 09 November 2020
Journal Article
PATH-16. HISTOPATHOLOGICAL EPENDYMOMA VARIANTS ARE ASSOCIATED WITH DISTINCT CLINICAL PARAMETERS AND DNA METHYLATION PATTERNS Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi146, https://doi.org/10.1093/neuonc/noz175.612
Published: 11 November 2019
